The battle between university powerhouses over who gets the credit for inventing the breakthrough gene-editing technology CRISPR could heat up again, according to a lawyer for the University of California at Berkeley.
Examiners with the U.S. Patent and Trademark Office have recommended a review, known as an interference, that would compare pending applications filed by the University of California at Berkeley and its partner the University of Vienna with patents issued to the Harvard University-affiliated Broad Institute, said Eldora Ellison of Sterne Kessler in Washington, one of the lawyers representing U.C. Berkeley on its patent issues.
The dispute is over ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.